| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles.
|
EMBO J
|
2007
|
1.44
|
|
2
|
Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
|
Chem Biol
|
2007
|
1.44
|
|
3
|
Energetic contribution of residues in the Runx1 Runt domain to DNA binding.
|
J Biol Chem
|
2003
|
1.12
|
|
4
|
Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
|
Nat Struct Biol
|
2002
|
0.92
|
|
5
|
Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.
|
Cancer Cell
|
2010
|
0.91
|
|
6
|
Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit.
|
J Biol Chem
|
2003
|
0.90
|
|
7
|
MQ-hCN-based pulse sequences for the measurement of 13C1'-1H1', 13C1'-15N, 1H1'-15N, 13C1'-13C2', 1H1'-13C2',13C6/8-1H6/8, 13C6/8-15N, 1H6/8-15N, 13C6-13C5, 1H6-13C5 dipolar couplings in 13C, 15N-labeled DNA (and RNA).
|
J Biomol NMR
|
2002
|
0.83
|